Xavier Matias-Guiu Guia

García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X

Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

CLINICAL & TRANSLATIONAL ONCOLOGY 16 243-256. 01/03/2014.

[doi:10.1007/s12094-013-1062-9]

Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

HUMAN PATHOLOGY 45 522-532. 01/03/2014.

[doi:10.1016/j.humpath.2013.10.018]

Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

Modern Pathology 27 304-304. 01/02/2014.

Bergada, L; Santacana, M; Garcia, V; Carceller, JA; Dolcet, X; Matias-Guiu, X

Role of Y-H2AX Expression in Prediction of Radiation Resistance in Endometrial Carcinoma

LABORATORY INVESTIGATION 94 276-276. 01/02/2014.

Macià A; Vaquero M; Gou-Fàbregas M; Castelblanco E; Valdivielso JM; Anerillas C; Mauricio D; Matias-Guiu X; Ribera J; Encinas M

Sprouty1 induces a senescence-associated secretory phenotype by regulating NFjB activity: implications for tumorigenesis

CELL DEATH AND DIFFERENTIATION 21 333-343. 01/02/2014.

[doi:10.1038/cdd.2013.161]

Veà, A.; Barrera, J.; Velasco, A.; Casanova, J.M.; Matias-Guiu, X.; Martí, R.M.

Utilidad de la siascopia en el diagnóstico de lesiones melanocíticas

Piel 29 654-659. 01/01/2014.

[doi:10.1016/j.piel.2014.05.003]

Huerva V; Soldevila J; Matias-Guiu X

Recurrent Amyloid Material in Grafts Used in Patients with Lattice Corneal Dystrophy 2 (Meretoja's Syndrome).

Medical hypothesis, discovery and innovation in ophthalmology 3 99-100. 01/01/2014.

Matias-Guiu, X.

Endometrial carcinoma: Pathological and molecular features

Endometrial Carcinoma: Pathological And Molecular Features 59-81. 01/01/2014.

Castelblanco, Esmeralda; Santacana, Maria; Valls, Joan; de Cubas, Aguirre; Cascon, Alberto; Robledo, Mercedes; Matias-Guiu, Xavier

Usefulness of Negative and Weak-Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas

ENDOCRINE PATHOLOGY 24 199-205. 01/12/2013.

[doi:10.1007/s12022-013-9269-4]

Romero-Perez, Laura; Angeles Lopez-Garcia, M.; Diaz-Martin, Juan; Biscuola, Michele; Angeles Castilla, M.; Tafe, Laura J.; Garg, Karuna; Oliva, Esther; Matias-Guiu, Xavier; Soslow, Robert A.; Palacios, Jose

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

Modern Pathology 26 1514-1524. 01/11/2013.

[doi:10.1038/modpathol.2013.93]

Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR

Redefining Stage I Endometrial Cancer Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 23 1620-1628. 01/11/2013.

[doi:10.1097/IGC.0b013e3182a5055e]

Das, Arindam; Pushparaj, Charumathi; Herreros, Judit; Nager, Mireia; Vilella, Ramon; Portero, Manuel; Pamplona, Reinald; Matias-Guiu, Xavier; Marti, Rosa M.; Canti, Carles

T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells

PIGMENT CELL & MELANOMA RESEARCH 26 874-885. 01/11/2013.

[doi:10.1111/pcmr.12155]